Inhibition mechanism of human galectin-7 by a novel galactose- benzylphosphate inhibitor

FEBS Journal

Volumn 279, Issue 2, 2012, Pages 193-202

  Masuyer, Geoffrey ^a   Jabeen, Talat ^a   Öberg, Christopher T ^b   Leffler, Hakon ^b   Nilsson, Ulf J ^b   Acharya, K Ravi ^a  

^a University of Bath   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

Author keywords

drug design; galactoside inhibitor; galectin 7; lectin

Indexed keywords

2 O BENZYLPHOSPHATE GALACTOSIDE; CARBOHYDRATE DERIVATIVE; GALECTIN 7; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 84855457490     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08414.x     Document Type: Article

References (40)

1. Barondes SH, Cooper DN, Gitt MA, &, Leffler H, (1994) Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269, 20807-20810.
2. Hirabayashi J, &, Kasai K, (1993) The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology 3, 297-304. (Pubitemid 23281277)
3. Leffler H, Carlsson S, Hedlund M, Qian Y, &, Poirier F, (2004) Introduction to galectins. Glycoconj J 19, 433-440. (Pubitemid 38316516)
4. Salomonsson E, Carlsson MC, Osla V, Hendus-Altenburger R, Kahl-Knutson B, Oberg CT, Sundin A, Nilsson R, Nordberg-Karlsson E, Nilsson UJ, et al. (2010) Mutational tuning of galectin-3 specificity and biological function. J Biol Chem 285, 35079-35091.
5. Vasta GR, (2009) Roles of galectins in infection. Nat Rev Microbiol 7, 424-438.
6. Rabinovich GA, &, Toscano MA, (2009) Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 9, 338-352.
7. Liu FT, &, Rabinovich GA, (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5, 29-41. (Pubitemid 40052323)
8. Delacour D, Koch A, &, Jacob R, (2009) The role of galectins in protein trafficking. Traffic 10, 1405-1413.
9. Haudek KC, Spronk KJ, Voss PG, Patterson RJ, Wang JL, &, Arnoys EJ, (2010) Dynamics of galectin-3 in the nucleus and cytoplasm. Biochim Biophys Acta 1800, 181-189.
10. Thiemann S, &, Baum LG, (2011) The road less traveled: regulation of leukocyte migration across vascular and lymphatic endothelium by galectins. J Clin Immunol 31, 2-9.
11. Glinskii OV, Huxley VH, Glinsky GV, Pienta KJ, Raz A, &, Glinsky VV, (2005) Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia 7, 522-527. (Pubitemid 40791870)
12. Zou J, Glinsky VV, Landon LA, Matthews L, &, Deutscher SL, (2005) Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis 26, 309-318. (Pubitemid 40246552)
13. Johnson KD, Glinskii OV, Mossine VV, Turk JR, Mawhinney TP, Anthony DC, Henry CJ, Huxley VH, Glinsky GV, Pienta KJ, et al. (2007) Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. Neoplasia 9, 662-670. (Pubitemid 47328085)
14. Lin CI, Whang EE, Donner DB, Jiang X, Price BD, Carothers AM, Delaine T, Leffler H, Nilsson UJ, Nose V, et al. (2009) Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Mol Cancer Res 7, 1655-1662.
15. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F, et al. (2010) Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 70, 6216-6224.
16. Stannard KA, Collins PM, Ito K, Sullivan EM, Scott SA, Gabutero E, Grice D, Low P, Nilsson UJ, Leffler H, et al. (2010) Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett 299, 95-110.
17. Morris S, Ahmad N, André S, Kaltner H, Gabius HJ, Brenowitz M, &, Brewer F, (2004) Quaternary solution structures of galectins-1, -3, and -7. Glycobiology 14, 293-300. (Pubitemid 38324944)
18. Madsen P, Rasmussen HH, Flint T, Gromov P, Kruse TA, Honoré B, Vorum H, &, Celis JE, (1995) Cloning, expression, and chromosome mapping of human galectin-7. J Biol Chem 270, 5823-5829.
19. Timmons PM, Colnot C, Cail I, Poirier F, &, Magnaldo T, (1999) Expression of galectin-7 during epithelial development coincides with the onset of stratification. Int J Dev Biol 43, 229-235. (Pubitemid 29268340)
20. Cao Z, Said N, Amin S, Wu HK, Bruce A, Garate M, Hsu DK, Kuwabara I, Liu FT, &, Panjwani N, (2002) Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds. J Biol Chem 277, 42299-42305. (Pubitemid 35257550)
21. Magnaldo T, Fowlis D, &, Darmon M, (1998) Galectin-7, a marker of all types of stratified epithelia. Differentiation 63, 159-168. (Pubitemid 28362380)
22. Ueda S, Kuwabara I, &, Liu FT, (2004) Suppression of tumor growth by galectin-7 gene transfer. Cancer Res 64, 5672-5676. (Pubitemid 39095564)
23. Moisan S, Demers M, Mercier J, Magnaldo T, Potworowski EF, &, St-Pierre Y, (2003) Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia 17, 751-759. (Pubitemid 36519372)
24. Demers M, Magnaldo T, &, St-Pierre Y, (2005) A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res 65, 5205-5210. (Pubitemid 40827330)
25. Demers M, Rose AAN, Grosset A, Biron-Pain K, Gaboury L, Siegel PM, &, St-Pierre Y, (2010) Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells. Am J Pathol 176, 3023-3031.
26. Leonidas DD, Vatzaki EH, Vorum H, Celis JE, Madsen P, &, Acharya KR, (1998) Structural basis for the recognition of carbohydrates by human galectin-7. Biochemistry 37, 13930-13940. (Pubitemid 28471225)
27. Salameh BA, Sundin A, Leffler H, &, Nilsson UJ, (2006) Thioureido N-acetyllactosamine derivatives as potent galectin-7 and 9N inhibitors. Bioorg Med Chem 14, 1215-1220. (Pubitemid 43059814)
28. Cumpstey I, Carlsson S, Leffler H, &, Nilsson UJ, (2005) Synthesis of a phenyl thio-β-d-galactopyranoside library from 1,5-difluoro-2,4- dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7. Org Biomol Chem 3, 1922-1932. (Pubitemid 40751363)
29. Öberg C, Noresson A, Leffler H, &, Nilsson UJ, (2011) Arene-anion based arginine-binding motif on a galactose scaffold: structure-activity relationships of interactions with arginine-rich galectins. Chem Eur J 17, 8139-8144.
30. Krissinel E, &, Henrick K, (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372, 774-797. (Pubitemid 47321791)
31. Diehl C, Engström O, Delaine T, HÃ¥kansson M, Genheden S, Modig K, Leffler H, Ryde U, Nilsson UJ, &, Akke M, (2010) Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3. J Am Chem Soc 132, 14577-14589.
32. Öberg CT, Blanchard H, Leffler H, &, Nilsson UJ, (2008) Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8. Bioorg Med Chem Lett 18, 3691-3694.
33. Sorme P, Arnoux P, Kahl-Knutsson B, Leffler H, Rini JM, &, Nilsson UJ, (2005) Structural and thermodynamic studies on cation- interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction. J Am Chem Soc 127, 1737-1743. (Pubitemid 40233025)
34. Carter CW, (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307-326.
35. Collaborative Computational Project, Number 4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50, 760-763.
36. Read RJ, (2001) Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr D Biol Crystallogr 57, 1373-1382. (Pubitemid 36117185)
37. Vagin AA, Steiner RS, Lebedev AA, Potterton L, McNicholas S, Long F, &, Murshudov GN, (2004) REFMAC5 dictionary: organisation of prior chemical knowledge and guidelines for its use. Acta Crystallogr D Biol Crystallogr 60, 2284-2295.
38. Sheldrick GM, (1997) SHELXL-97. Program for the Refinement of Crystal Structures. University of Göttingen, Germany.
39. Emsley P, &, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132. (Pubitemid 41742764)
40. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB, Snoeyink J, Richardson JS, et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35, W375-W383.